Evidence map›Paper›PMID 29774388›Full record

ArticleIntensive care medicine2018

Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit.

Bertrand Guidet, Hans Flaatten, Ariane Boumendil, Alessandro Morandi, Finn H Andersen, Antonio Artigas, Guido Bertolini, Maurizio Cecconi, Steffen Christensen, Loredana Faraldi and 14 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07035951 (The VIP-3), which is not on this map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
22.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07035951 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

The VIP-3 (Very Old Intensive Care Patients) Study: Decision-making in the Older Intensive Care Unit (ICU) Patient: How Are Family Meetings Implemented Across Diverse Cultures in Europe?

TypeobservationalSponsorSt George's, University of LondonRan2025 to 2026Enrolled2,000ConditionsFamily Members, Critical Illness, Frailty, Communication
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 215 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Extracorporeal Cytokine Hemadsorption with oXirisJournal of clinical medicine · 2026
    Article
  7. Observational
  8. Observational
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Observational
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 19 institutions in 15 countries.

Bertrand GuidetHôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, 184 rue du Faubourg Saint Antoine, 75012, Paris, France. bertrand.guidet@aphp.fr.ORCID http://orcid.org/0000-0002-7643-6770
Hans FlaattenDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Ariane BoumendilHôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, 184 rue du Faubourg Saint Antoine, 75012, Paris, France. ariane.boumendil@gmail.com.
Alessandro MorandiDepartment of Rehabilitation, Hospital Ancelle di Cremona, Cremona, Italy.
Finn H AndersenDepartment of Anaesthesia and Intensive Care, Ålesund Hospital, Ålesund, Norway.
Antonio ArtigasDepartment of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
Guido BertoliniLaboratorio di Epidemiologia Clinica, Centro di Coordinamento GiViTI Dipartimento di Salute Pubblica, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri" Villa Camozzi, 24020, Ranica, Bergamo, Italy.
Maurizio CecconiSt George's University Hospital, London, UK.
Steffen ChristensenDepartment of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Åarhus, Denmark.
Loredana FaraldiGrande Ospedale Metropolitano Niguarda, Milan, Italy.
Jesper FjølnerDepartment of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Åarhus, Denmark.
Christian JungDepartment of Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany.
Brian MarshMater Misericordiae University Hospital, Dublin, Ireland.
Rui MorenoUnidade de Cuidados Intensivos Polivalente Neurocríticos, Hospital de São José, Centro Hospitalar de Lisboa Central, Faculdade de Ciência Médicas de Lisboa, Nova Médical School, Lisbon, Portugal.
Sandra OeyenDepartment of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium.
Christina Agwald ÖhmanKarolinska University Hospital, Solna, Sweden.
Bernardo Bollen PintoGeneva University Hospitals, Geneva, Switzerland.
Ivo W SolimanDepartment of Intensive Care, University Medical Center, University Utrecht, Utrecht, The Netherlands.
Wojciech SzczeklikIntensive Care and Perioperative Medicine Division, Jagiellonian University Medical College, Kraków, Poland.
Andreas ValentinKardinal Schwarzenberg Hospital, Schwarzach, Austria.
Ximena WatsonSt George's University Hospital, London, UK.
Tilemachos ZafeiridisIntensive Care Unit General Hospital of Larissa, Larissa, Greece.
Dylan W De LangeDepartment of Intensive Care, University Medical Center, University Utrecht, Utrecht, The Netherlands.
VIP1 study group
Aarhus University Hospital · DKDüsseldorf University Hospital · DEUniversity Medical Center Utrecht · NLÅlesund Hospital · NOGhent University Hospital · BEHaukeland University Hospital · NOInserm · FRJagiellonian University · PLMater Misericordiae University Hospital · IESt George's Hospital · GBUniversity Hospital of Geneva · CHAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITGruppo di Ricerca Geriatrica · ITKarolinska University Hospital · SEMario Negri Institute for Pharmacological Research · ITSorbonne Université · FRUnidade Local de Saúde de São José · PTUniversitat Autònoma de Barcelona · ESUniversity Hospital of Larissa · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo document and analyse the decision to withhold or withdraw life-sustaining treatment (LST) in a population of very old patients admitted to the ICU.

methodsThis prospective study included intensive care patients aged ≥ 80 years in 309 ICUs from 21 European countries with 30-day mortality follow-up.

resultsLST limitation was identified in 1356/5021 (27.2%) of patients: 15% had a withholding decision and 12.2% a withdrawal decision (including those with a previous withholding decision). Patients with LST limitation were older, more frail, more severely ill and less frequently electively admitted. Patients with withdrawal of LST were more frequently male and had a longer ICU length of stay. The ICU and 30-day mortality were, respectively, 29.1 and 53.1% in the withholding group and 82.2% and 93.1% in the withdrawal group. LST was less frequently limited in eastern and southern European countries than in northern Europe. The patient-independent factors associated with LST limitation were: acute ICU admission (OR 5.77, 95% CI 4.32-7.7), Clinical Frailty Scale (CFS) score (OR 2.08, 95% CI 1.78-2.42), increased age (each 5 years of increase in age had a OR of 1.22 (95% CI 1.12-1.34) and SOFA score [OR of 1.07 (95% CI 1.05-1.09 per point)]. The frequency of LST limitation was higher in countries with high GDP and was lower in religious countries.

conclusionsThe most important patient variables associated with the instigation of LST limitation were acute admission, frailty, age, admission SOFA score and country.

trial registrationClinicalTrials.gov (ID: NTC03134807).

Indexed as

Life Support CareWithholding TreatmentAged, 80 and overDecision MakingEuropeHumansIntensive Care UnitsMaleProspective StudiesElderlyEthicsIntensive careLife sustaining treatmentWithdrawalWithholding

Identifiers

PMID29774388
OpenAlexW2804012113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.